surpass 2 tirzepatide versus Semaglutide in Type Diabetes (SURPASS-2) | NEJM Efficacy of tirzepatide 5, 10

At the time the MDL was formed, at least 30 Ozempic vision-loss claims were consolidated into the federal group lawsuit

This all goes hand-in-hand with anti-aging benefits and overall general improved levels of wellbeing

This regulatory change was primarily driven by safety concerns associated with compounded drugs, which have not been subjected to the same level of scrutiny as their branded counterparts

TZP was started at 2.5 mg once a week and progressively titrated by 2.5 mg every four weeks

Even light movementsuch as leisurely walkingproduces measurable improvements in bowel function

The key message is clear: these treatments are powerful, but their long-term public health impact will depend on whether the right support systems are in place to ensure equitable and safe access for all patients. This comes as a new semaglutide 7.2mg single-dose pen has been launched by Novo Nordisk as a maintenance dose for adults with obesity, following approval from the Medicines and Healthcare products Regulatory Agency